Table 2.
EUBD results of malignant proximal biliary obstruction.
| EUBD (n = 18) | |
|---|---|
| Technical success of hepaticogastrostomy, n (%) | 17 (94) |
| Technical success of bridge-trans-hilar stenting, n (%)a | 3 (50) |
| Clinical success, n (%) | |
| Early (at 7 days) | 13 (72.2) |
| Sustained (at 30 days) b | 11 (68.8) |
| Total bilirubin, mean (SD), mg/dl | |
| 1 week | 6.5 (5) |
| 1 month | 3.8 (5.8) |
| Reintervention rate, n (%) | 3 (16.7) |
| Hospitalization length, days median (range) | 10 (6–35) |
| Complication rates at 3 months, n (%) | 3 (16.7) |
| Procedure-related mortality <1 week n (%) | 1 (5.6) |
| Overall survival, days, median (range) | 79 (5–390) |
| Chemotherapy administration, n (%) | 10 (55.6) |
| Overall survival of patients with chemotherapy, days, median (range) | 210 (32–390) |
a
Six attempts to put bridge-trans-hilar prosthesis in five patients.
b
Two patients excluded because of early death with no connection to drainage.